LONDON 24 May 2020: Biopharmaceutical company, AstraZeneca, said on Thursday it had received the first agreements to supply at least 400 million doses of the Covid-19 vaccine it is developing with the University of Oxford, reported Reuters.
The British drugmaker said it has a total capacity sourced for one billion doses through 2020 and into 2021, and continues to increase capacity further, said Wam.
CLICK FOR MORE NEWS ABOUT CORONAVIRUS
ALSO READ:
